Literature DB >> 20461801

Analysis of the factors influencing the cardiac phenotype in Friedreich's ataxia.

Bheeshma Rajagopalan1, Jane M Francis, Fraser Cooke, L V Prasad Korlipara, Andrew M Blamire, Anthony H V Schapira, Jason Madan, Stefan Neubauer, J Mark Cooper.   

Abstract

Friedreich's ataxia (FRDA) has been associated with both cardiac hypertrophy and to a lesser degree dilated cardiomyopathy. We have conducted a cross sectional magnetic resonance imaging (MRI) study of 25 patients with clinically and genetically confirmed FRDA and 24 healthy controls to analyse how disease parameters influence cardiac features in FRDA. MR cine imaging in the long and short axis planes was performed alongside clinical assessments. LV mass was most pronounced in FRDA patients with a larger genetic mutation (GAA1 repeats >600), earlier age of onset (<16years) and a shorter disease duration (<15 years). LV mass decreased with longer disease duration (>15 years), and independent of GAA1 repeat size and age of onset, suggesting cardiac thinning occurred with prolonged disease. Heart function was lower in patients with larger GAA1 repeat number and longer disease duration. Consequently, cardiac hypertrophy was more marked in FRDA patients with a larger GAA1 repeat number and younger age of onset, while prolonged disease duration was associated with lower LV mass and decreased heart function. It is important not only to understand the biochemical basis for these cardiac changes but also allow for these changes when assessing the effect of treatment of FRDA patients. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20461801     DOI: 10.1002/mds.22864

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

Review 1.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis, Prognosis, and Treatment of Infiltrative Cardiomyopathies.

Authors:  Praveen G Ranganath; Albree Tower-Rader
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

2.  Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development.

Authors:  R Mark Payne; P Melanie Pride; Clifford M Babbey
Journal:  Pediatr Cardiol       Date:  2011-03-01       Impact factor: 1.655

3.  Common data elements for clinical research in Friedreich's ataxia.

Authors:  David R Lynch; Massimo Pandolfo; Jorg B Schulz; Susan Perlman; Martin B Delatycki; R Mark Payne; Robert Shaddy; Kenneth H Fischbeck; Jennifer Farmer; Paul Kantor; Subha V Raman; Lisa Hunegs; Joanne Odenkirchen; Kristy Miller; Petra Kaufmann
Journal:  Mov Disord       Date:  2012-12-12       Impact factor: 10.338

Review 4.  [Heart involvement in Friedreich's ataxia].

Authors:  F Weidemann; F Scholz; C Florescu; D Liu; K Hu; S Herrmann; G Ertl; S Störk
Journal:  Herz       Date:  2014-05-23       Impact factor: 1.443

5.  The Heart in Friedreich's Ataxia: Basic Findings and Clinical Implications.

Authors:  R Mark Payne
Journal:  Prog Pediatr Cardiol       Date:  2011-05

Review 6.  Cardiomyopathy in Friedreich ataxia: clinical findings and research.

Authors:  R Mark Payne; Gregory R Wagner
Journal:  J Child Neurol       Date:  2012-07-04       Impact factor: 1.987

7.  Investigation of cardiomyopathy using cardiac magnetic resonance imaging part 2: Rare phenotypes.

Authors:  Ailbhe C O'Neill; Shaunagh McDermott; Carole A Ridge; David Keane; Jonathan D Dodd
Journal:  World J Cardiol       Date:  2012-05-26

Review 8.  Clinical features of Friedreich ataxia.

Authors:  Martin B Delatycki; Louise A Corben
Journal:  J Child Neurol       Date:  2012-06-29       Impact factor: 1.987

9.  Uncharted waters: rare and unclassified cardiomyopathies characterized on cardiac magnetic resonance imaging.

Authors:  Ailbhe C O'Neill; Shaunagh McDermott; Carole A Ridge; Kenneth McDonald; David Keane; Jonathan D Dodd
Journal:  Insights Imaging       Date:  2010-10-19

10.  Crucial function of vertebrate glutaredoxin 3 (PICOT) in iron homeostasis and hemoglobin maturation.

Authors:  Petra Haunhorst; Eva-Maria Hanschmann; Lars Bräutigam; Oliver Stehling; Bastian Hoffmann; Ulrich Mühlenhoff; Roland Lill; Carsten Berndt; Christopher Horst Lillig
Journal:  Mol Biol Cell       Date:  2013-04-24       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.